Summary of clinical characteristics of four patients with WAS gene mutation with large vessel vasculopathy in our cohort
| | Patient 1 | Patient 2 | Patient 3 | Patient 4 |
|---|---|---|---|---|
| Age of presentation | 5 years | 3.5 years | 11 years | 11.8 years |
| Age of onset of initial symptoms | Infancy | 2 years | 8 years | 11.4 years |
| Age at diagnosis of WAS | 5 years | 3.5 years | 11 years | 11.8 years |
| Age at the time of vasculitis manifestations | 16 years | 10 years | 11 years | 11.4 years |
| Presenting complaints | Acute febrile encephalopathy, seizures, right-sided lower motor neuron facial nerve palsy, bilateral lateral rectus palsy | Recurrent abdominal pain | Polyarthritis, recurrent abdominal pain, cough, hypertension, cardiac dysfunction | Abdominal pain, neck pain, left upper limb claudication |
| Lymphoproliferation | Present | Present | Present | Absent |
| Past infections | ||||
| Bacterial infections | Sinopulmonary infections, pyogenic meningitis, pulmonary Tuberculosis | Sinopulmonary infections | None | None |
| Viral infections | None | Warts, extensive molluscum contagiosum | None | None |
| Autoimmune manifestations, if any | DCT negative autoimmune hemolytic anemia | Autoimmune hemolytic anemia | Arthritis, ANA negative, DCT negative | None |
| Eczema | ++ | ++ | − | − |
| IVIg prophylaxis at the time of vasculitis | Noncompliant | Noncompliant | Not initiated | Not initiated |
| EBV viral load | 9720 copies/ml | 38,880 copies/ml | Negative | 5200 copies |
| CMV PCR, Serology:(HIV, HSV, HCV) and HBsAg | Negative | Negative | Negative | Negative |
| Investigations | ||||
| MPV (fl) | 6.7 | 6.8 | 7.4 | 6.1 |
| Lowest platelet counts at presentation with vasculitis (×109/L) | 2.9 | 35 | 69 | 136 |
| Immunoglobulin profile | ||||
| IgG (g/L) (N:5–16) | 12.4 | 7.5 | 6.67 | 14.9 |
| IgM (g/L) (N:0.5–2) | 1.35 | 0.24 | 0.47 | 0.50 |
| IgA (g/L) (N:0.4–2) | 0.59 | 5.68 | 1.92 | 5.83 |
| IgE (KU/L; N<100) | 370 | 6720 | 786 | 1256 |
| Lymphocyte Subset analysis | ||||
| CD3+ T lymphocytes (N: 55–75%) | 61.9% | 76.64% | 56.9% | 86.5% |
| CD19+ B lymphocytes (N: 10–30%) | 7.6% | 4.99% | 30.58% | 5.09% |
| CD16/56+ NK cells (N:4–23%) | 7.3% | 10.69% | 11.81% | 7.14% |
| CD3+ CD4+ T cell (N:27–53%) | 36.25% | 36.25% | 69.75% | 71.6% |
| CD3+ CD8+ T cell (N: 19–34%) | 55.97% | 55.97% | 21.14% | 19.4% |
| CD4:CD8 ratio (N: 0.9–3.6) | 0.65 | 0.65 | 3.3 | 4.1 |
| CD4+ CD127– CD25+ (Tregs) (N: 5–10%) | 4% | 4% | 14.45% | 8.8% |
| WAS protein expression | ||||
| Delta MFI | Patient: 1200 | Patient: 281 | Patient: 1495 | Patient: 5128 |
| Control: 4300 | Control: 1087 | Control: 4761 | Control: 7875 | |
| Stain index | Patient: 4 | Patient: 4.17 | Patient: 159 | Patient: 145.46 |
| Control: 15.33 | Control 8.68 | Control: 428 | Control: 65.68 | |
| WAS protein | Reduced | Reduced | Reduced | Normal |
| WAS gene variant | c.1021+2T>G, Intron 10-IVS 10+2 T>G | Exon 1 c.37C>T; p.R13* | Exon 2 c.256C>T, p.Arg86Cys | Exon 1 c.103 C>T, p.Leu35Phe |
| Arterial involvement | Thoracic and suprarenal part of abdominal aorta, critical focal luminal narrowing of brachiocephalic trunk at its origin with complete luminal occlusion of left subclavian artery and left common carotid artery | Abdominal aorta extending from diaphragmatic hiatus to bifurcation (L5 vertebral level). Variable length of proximal coeliac trunk, superior mesenteric artery and left renal artery showed fusiform dilatations | Suprarenal and renal segments and short infrarenal segment of the abdominal aorta, celiac artery origin, anterior right renal artery, posterior right renal artery | Long segment occlusion / tight stenosis of left subclavian artery. |
| | Patient 1 | Patient 2 | Patient 3 | Patient 4 |
|---|---|---|---|---|
| Age of presentation | 5 years | 3.5 years | 11 years | 11.8 years |
| Age of onset of initial symptoms | Infancy | 2 years | 8 years | 11.4 years |
| Age at diagnosis of WAS | 5 years | 3.5 years | 11 years | 11.8 years |
| Age at the time of vasculitis manifestations | 16 years | 10 years | 11 years | 11.4 years |
| Presenting complaints | Acute febrile encephalopathy, seizures, right-sided lower motor neuron facial nerve palsy, bilateral lateral rectus palsy | Recurrent abdominal pain | Polyarthritis, recurrent abdominal pain, cough, hypertension, cardiac dysfunction | Abdominal pain, neck pain, left upper limb claudication |
| Lymphoproliferation | Present | Present | Present | Absent |
| Bacterial infections | Sinopulmonary infections, pyogenic meningitis, pulmonary Tuberculosis | Sinopulmonary infections | None | None |
| Viral infections | None | Warts, extensive molluscum contagiosum | None | None |
| Autoimmune manifestations, if any | DCT negative autoimmune hemolytic anemia | Autoimmune hemolytic anemia | Arthritis, ANA negative, DCT negative | None |
| Eczema | ++ | ++ | − | − |
| IVIg prophylaxis at the time of vasculitis | Noncompliant | Noncompliant | Not initiated | Not initiated |
| EBV viral load | 9720 copies/ml | 38,880 copies/ml | Negative | 5200 copies |
| CMV PCR, Serology:(HIV, HSV, HCV) and HBsAg | Negative | Negative | Negative | Negative |
| MPV (fl) | 6.7 | 6.8 | 7.4 | 6.1 |
| Lowest platelet counts at presentation with vasculitis (×109/L) | 2.9 | 35 | 69 | 136 |
| IgG (g/L) (N:5–16) | 12.4 | 7.5 | 14.9 | |
| IgM (g/L) (N:0.5–2) | 1.35 | 0.50 | ||
| IgA (g/L) (N:0.4–2) | 0.59 | 1.92 | ||
| IgE (KU/L; N<100) | ||||
| CD3+ T lymphocytes (N: 55–75%) | 61.9% | 76.64% | ||
| CD19+ B lymphocytes (N: 10–30%) | ||||
| CD16/56+ NK cells (N:4–23%) | 7.3% | 10.69% | 11.81% | 7.14% |
| CD3+ CD4+ T cell (N:27–53%) | 36.25% | 36.25% | ||
| CD3+ CD8+ T cell (N: 19–34%) | 21.14% | |||
| CD4:CD8 ratio (N: 0.9–3.6) | 3.3 | |||
| CD4+ CD127– CD25+ (Tregs) (N: 5–10%) | 4% | 4% | 8.8% | |
| Delta MFI | Patient: 1200 | Patient: 281 | Patient: 1495 | Patient: 5128 |
| Control: 4300 | Control: 1087 | Control: 4761 | Control: 7875 | |
| Stain index | Patient: 4 | Patient: 4.17 | Patient: 159 | Patient: 145.46 |
| Control: 15.33 | Control 8.68 | Control: 428 | Control: 65.68 | |
| WAS protein | Reduced | Reduced | Reduced | Normal |
| c.1021+2T>G, Intron 10-IVS 10+2 T>G | Exon 1 c.37C>T; p.R13* | Exon 2 c.256C>T, p.Arg86Cys | Exon 1 c.103 C>T, p.Leu35Phe | |
| Arterial involvement | Thoracic and suprarenal part of abdominal aorta, critical focal luminal narrowing of brachiocephalic trunk at its origin with complete luminal occlusion of left subclavian artery and left common carotid artery | Abdominal aorta extending from diaphragmatic hiatus to bifurcation (L5 vertebral level). Variable length of proximal coeliac trunk, superior mesenteric artery and left renal artery showed fusiform dilatations | Suprarenal and renal segments and short infrarenal segment of the abdominal aorta, celiac artery origin, anterior right renal artery, posterior right renal artery | Long segment occlusion / tight stenosis of left subclavian artery. |
Bold values indicate abnormal values.
N, age related normal values; WAS, Wiskott Aldrich syndrome; DCT, direct coombs test; fl, femtoliter; ANA, Anti nuclear antibody; IVIg, intravenous immunoglobulin; NK cell, natural killer cells, Tregs, Regulatory T cells; MFI, mean fluorescence index; EBV, Epstein barr virus; PCR, polymerase chain reaction, HIV-Human immunodeficiency virus; HSV, herpes simplex virus; HCV, Hepatitis C Virus; HBsAg, Hepatitis B surface antigen.